Procyon Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472K | Sell |
6,839
-23,643
| -78% | -$1.63M | 0.04% | 289 |
|
|
2025
Q1 | $2.07M | Buy |
+30,482
| New | +$2.07M | 0.12% | 166 |
|
|
2024
Q4 | – | Sell |
-3,242
| Closed | -$202K | – | 548 |
|
|
2024
Q3 | $202K | Buy |
+3,242
| New | +$202K | 0.01% | 525 |
|
|
2024
Q2 | – | Sell |
-3,464
| Closed | -$276K | – | 529 |
|
|
2024
Q1 | $276K | Sell |
3,464
-225
| -6% | -$17.9K | 0.02% | 432 |
|
|
2023
Q4 | $291K | Buy |
3,689
+557
| +18% | +$44K | 0.02% | 421 |
|
|
2023
Q3 | $219K | Buy |
3,132
+46
| +1% | +$3.21K | 0.02% | 439 |
|
|
2023
Q2 | $213K | Buy |
3,086
+78
| +3% | +$5.39K | 0.03% | 421 |
|
|
2023
Q1 | $224K | Sell |
3,008
-171
| -5% | -$12.7K | 0.04% | 349 |
|
|
2022
Q4 | $296K | Buy |
3,179
+695
| +28% | +$64.8K | 0.05% | 295 |
|
|
2022
Q3 | $237K | Sell |
2,484
-12
| -0.5% | -$1.15K | 0.06% | 279 |
|
|
2022
Q2 | $231K | Sell |
2,496
-5,677
| -69% | -$525K | 0.05% | 282 |
|
|
2022
Q1 | $827K | Buy |
8,173
+5,416
| +196% | +$548K | 0.17% | 118 |
|
|
2021
Q4 | $284K | Buy |
2,757
+107
| +4% | +$11K | 0.06% | 261 |
|
|
2021
Q3 | $225K | Sell |
2,650
-466
| -15% | -$39.6K | 0.06% | 283 |
|
|
2021
Q2 | $260K | Sell |
3,116
-1,291
| -29% | -$108K | 0.07% | 246 |
|
|
2021
Q1 | $332K | Sell |
4,407
-469
| -10% | -$35.3K | 0.15% | 153 |
|
|
2020
Q4 | $333K | Buy |
4,876
+446
| +10% | +$30.5K | 0.16% | 139 |
|
|
2020
Q3 | $259K | Buy |
4,430
+141
| +3% | +$8.24K | 0.14% | 154 |
|
|
2020
Q2 | $279K | Buy |
4,289
+1,566
| +58% | +$102K | 0.15% | 132 |
|
|
2020
Q1 | $162K | Buy |
2,723
+428
| +19% | +$25.5K | 0.11% | 179 |
|
|
2019
Q4 | $170K | Buy |
+2,295
| New | +$170K | 0.1% | 191 |
|